真实世界观察性研究,针对多发性硬化症接受ocrelizumab治疗的人群的感染
Laura Davies1, Rasheed Shehadeh2, W John Watkins2
1Helen Durham Neuro-Inflammatory Unit, University Hospital of Wales, Cardiff, CF14 4XW, UK.
Journal of neurology
|May 22, 2025
概括
多发性硬化症 (MS) 的ocrelizumab治疗会随着时间的推移增加感染风险,特别是在患有并发症的老年女性中. 较低的免疫球蛋白水平与感染增加和抗体反应减少相关.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 反CD20单克隆抗体是多发性硬化症 (MS) 的标准一线治疗方法.
- 奥克雷利祖马布,利图西马布和奥法图穆马布与低血糖球蛋白血症有关,但其临床意义尚不清楚.
研究的目的:
- 评估使用ocrelizumab治疗的MS患者的感染率及其与免疫球蛋白水平的关联.
- 为了研究在ocrelizumab治疗期间感染的风险因素.
主要方法:
- 一项对152名接受ocrelizumab治疗的多发性硬化症患者的观察性研究.
- 随访时间长达5.6年 (平均2.7年).
主要成果:
- 在Ocrelizumab治疗的前4年内,感染率显著增加.
- 感染风险与免疫球蛋白水平,年龄,并发症和性别有关.
- 87%的患有低正常IgG的患者对肺炎球菌/Hemophilus influenzae.表现出不充分的抗体反应.
结论:
- 关于ocrelizumab的现实世界数据补充了临床试验.
- 虽然严重的感染很少发生,但不严重的感染在使用ocrelizumab时变得更常见.
- 建议在抗CD20治疗期间采取降低感染风险的策略.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Factors Affecting the Risk of Infection
11.5K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.5K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.1K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.1K
Principles of Disease Surveillance
77
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
77


